Trial Profile
Phase III Study of S-555739 in Patients with Seasonal Allergic Rhinitis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Jun 2016
Price :
$35
*
At a glance
- Drugs Asapiprant (Primary)
- Indications Allergic rhinitis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Shionogi
- 07 Jun 2016 New trial record